{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:09:44Z","timestamp":1790402984224,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.jinf.2005.04.007","type":"journal-article","created":{"date-parts":[[2005,5,20]],"date-time":"2005-05-20T09:21:17Z","timestamp":1116580877000},"page":"92-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)\u2014a report of ten cases"],"prefix":"10.1016","volume":"52","author":[{"given":"Bent","family":"von der Lippe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Sandven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oddbj\u00f8rn","family":"Brubakk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2005.04.007_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1021\/jm9509556","article-title":"Synthesis and antibacterial activity of U-100592 and U-100766, two oxalidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections","volume":"39","author":"Brickner","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.jinf.2005.04.007_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.40.4.839","article-title":"In vitro activities of U-100592 and U-100766 novel oxalidinone antibacterial agents","volume":"40","author":"Zurenko","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.04.007_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/AAC.43.5.1189","article-title":"Activities of several novel oxalidinones against Mycobacterium tuberculosis in a murine model","volume":"43","author":"Cynamon","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.04.007_bib4","first-page":"A868","article-title":"Linezolid: a promising new agent for multidrug resistant tuberculosis treatment","volume":"167","author":"Hadjiangelis","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2005.04.007_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/14656566.2.2.293","article-title":"Linezolid\u2014a review of the first oxalidinone","volume":"2","author":"Norrby","year":"2001","journal-title":"Exp Opin Pharmacother"},{"key":"10.1016\/j.jinf.2005.04.007_bib6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00003495-200059040-00007","article-title":"Linezolid","volume":"59","author":"Clemett","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jinf.2005.04.007_bib7","series-title":"Manual of clinical microbiology","first-page":"1161","article-title":"Susceptibility test mehods: mycobacteria","author":"Inderlid","year":"2003"},{"key":"10.1016\/j.jinf.2005.04.007_bib8","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/JCM.37.10.3179-3186.1999","article-title":"Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs using the radiometric BACTEC 460 technique and the proportion method with solid media","volume":"37","author":"Pfyffer","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2005.04.007_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/dkf215","article-title":"The effect and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or have failed to respond to vancomycin","volume":"50","author":"Moise","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2005.04.007_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/380449","article-title":"Treating foot infections in diabetic patients: a randomized, multicenter, open label trial of linezolid versus ampicillin-sulbactam\/ampicillin-clavulanate","volume":"38","author":"Lipsky","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.04.007_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/345744","article-title":"Linezolid for the treatment of multidrug resistant, Gram-positive infections: experience from a compassionate-use program","volume":"36","author":"Birmingham","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2005.04.007_bib12","article-title":"Linezolid and peripheral neuropathy","volume":"22","author":"Toyliss","year":"2003","journal-title":"Aust Adverse Drug React Bull"},{"key":"10.1016\/j.jinf.2005.04.007_bib13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/379012","article-title":"Linezolid-associated toxic optic neuropathy: a report of 2 cases","volume":"37","author":"Lee","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.04.007_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1086\/381762","article-title":"Linezolid-induced neuropathy","volume":"38","author":"Legout","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.04.007_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/pgmj.48.565.667","article-title":"Peripheral neuropathy with ethambutol","volume":"48","author":"Tugwell","year":"1972","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jinf.2005.04.007_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1378\/chest.77.1.98","article-title":"Peripheral neuropathy associated with ethambutol","volume":"77","author":"Nair","year":"1980","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2005.04.007_bib17","first-page":"4555","article-title":"Ethambutol neuropathy: clinical and electroneuromyographic studies","volume":"34","author":"Tacheuchi","year":"1980","journal-title":"Folia Psychiatr Neurol Jpn"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:29:07Z","timestamp":1758986947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445305001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0163445305001015"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2005.04.007","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)\u2014a report of ten cases","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2005.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}